Furthermore, the subgroup analysis illustrated that the inflammatory cytokines VEGF, IL‐6, IL‐17, and IFN‐α might be novel biomarkers for predicting the survival prognosis of patients with advanced HCC and PVTT treated with TACE+LEN + PD‐1. The gene discussed is IL17A; the disease is hepatocellular carcinoma.